Application for quotation of +securities

Announcement Summary

For personal use only

Entity name

THE HYDRATION PHARMACEUTICALS COMPANY LIMITED

Announcement Type

New announcement

Date of this announcement

Thursday June 30, 2022

The +securities to be quoted are:

+Securities issued under an +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer

Total number of +securities to be quoted

ASX +security

Number of +securities to

code

Security description

be quoted

Issue date

HPC

ORDINARY FULLY PAID

1,547,779

30/06/2022

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 9

Application for quotation of +securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

THE HYDRATION PHARMACEUTICALS COMPANY LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2

Registered number type

Registration number

ACN

620385677

1.3

ASX issuer code

HPC

  1. The announcement is New announcement
  2. Date of this announcement

30/6/2022

Application for quotation of +securities

2 / 9

Application for quotation of +securities

Part 2 - Type of Issue

For personal use only

2.1 The +securities to be quoted are:

+Securities issued under an +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer

2.2 The +securities to be quoted are:

Additional +securities in a class that is already quoted on ASX ("existing class")

Application for quotation of +securities

3 / 9

Application for quotation of +securities

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

For personal use only

Additional +securities to be quoted in an existing class issued under an +employee incentive scheme

FROM (Existing Class)

ASX +security code and description

No security currently exists

FROM (Existing Class) +Security description

Performance Rights EXP 31/12/25

TO (Existing Class)

ASX +security code and description

HPC : ORDINARY FULLY PAID

Please state the number of +securities issued under the +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer

1,547,779

Please provide details of a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02465485-2A1345410?access_token=8 3ff96335c2d45a094df02a206a39ff4

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02513524-3A592241?access_token=83 ff96335c2d45a094df02a206a39ff4

Are any of these +securities being issued to +key management personnel (KMP) or an +associate Yes

Provide details of the KMP or +associates being issued +securities

Name of KMP

Name of registered holder

Number of +securities

682,509

Oliver Baker

Oliver Baker

555,542

Chris Kavanaugh

Chris Kavanaugh

Application for quotation of +securities

4 / 9

Application for quotation of +securities

Issue date 30/6/2022

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?

Yes

only

Issue details

use

Number of +securities to be quoted

1,547,779

Are the +securities being issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

personalFor

The Shares have been issued upon conversion of Performance Rights under the Company's EIP.

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted

0.120000

Any other information the entity wishes to provide about the +securities to be quoted

Estimated value based on HPC closing price at the last trading day prior to the issue of the Shares.

Application for quotation of +securities

5 / 9

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Hydration Pharmaceuticals Co. Ltd. published this content on 30 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 June 2022 06:41:10 UTC.